Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: oral

Currently viewing:

Administrative data

Endpoint:
sub-chronic toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
no data
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: peer reviewed published data, NTP study

Data source

Reference
Reference Type:
publication
Title:
Unnamed
Year:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
other: NTP study
Principles of method if other than guideline:
NTP
Dose range finding study for carcinogenicity assay
7 weeks treatment + 1 week observation
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Reference substance name:
Piperonyl butoxide
IUPAC Name:
Piperonyl butoxide
Details on test material:
PBO technical grade
Lot No 5
piperonyl butoxide, 88.4%
Niagara Chemical Company FMC, Middleport, new York, USA

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Frederick Cancer Research Center
- Age at study initiation: 4 weeks
- Weight at study initiation: 80-105 g
- Fasting period before study: not applicable
- Housing:
- Diet ad libitum
- Water ad libitum
- Acclimation period: 2 week

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22-24
- Humidity (%): 45-55
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light):12/12

IN-LIFE DATES: From: To: no data

Administration / exposure

Route of administration:
oral: feed
Vehicle:
other: with feed
Details on oral exposure:
Test diets containing piperonyl butoxide were prepared fresh each
week in 6- to 12-kilogram batches at appropriate doses. A known
weight of the chemical was first mixed with an equal weight of
autoclaved Wayne® Sterilizable Lab Meal (Allied Mills, Inc.,
Chicago, 111.), using a mortar and pestle. The mixing was
repeated with second and third additions of feed, and final
mixing was performed with the remaining quantity of feed for a
minimum of 15 minutes in a Patterson-Kelly twin-shell blender.
The diets were stored at 7 C in plastic bags during the 1 to
1-1/2 weeks it was used.
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
7 weeks + 1 week additional observation
Frequency of treatment:
daily
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0, 1.47%, 2.15%, 3.15%, 4.6%, 6.8%
Basis:
nominal in diet
Remarks:
Doses / Concentrations:
0, 1323, 1935, 2835, 4140, 6120 mg/kg bw/day
Basis:
other: calculated using a factor 0f 0.09 mg/kg bw/d/ ppm
No. of animals per sex per dose:
5
Control animals:
yes, plain diet
Details on study design:
no data
Positive control:
not applicable

Examinations

Observations and examinations performed and frequency:
Daily observation for mortality
Clinicla signs,
body weight: twice per week
Food and water consumption on days 4, 11, 18, 39 for 6 rats per group
Sacrifice and pathology:
organ weights and relative organe weights determined for:
liver, brain, heart, kidney, spleen, lung, testis, prostate, adrenal, thymus, ovary, uterus
Other examinations:
Haematological and clinical chemical examinations
Histological examinations of liver and kidney

Results and discussion

Results of examinations

Clinical signs:
effects observed, treatment-related
Description (incidence and severity):
All animals died at the highest dose level; 4 males and 3 female sdied at the 4.6% dose level, no moratlites at 1.47-3.31%
Mortality:
mortality observed, treatment-related
Description (incidence):
All animals died at the highest dose level; 4 males and 3 female sdied at the 4.6% dose level, no moratlites at 1.47-3.31%
Body weight and weight changes:
effects observed, treatment-related
Description (incidence and severity):
No effect at 1.47%, reduced body weight at higher dose levesl.
Food consumption and compound intake (if feeding study):
not specified
Food efficiency:
not specified
Water consumption and compound intake (if drinking water study):
not specified
Ophthalmological findings:
not examined
Haematological findings:
not examined
Clinical biochemistry findings:
not examined
Urinalysis findings:
not examined
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
not examined
Gross pathological findings:
not specified
Histopathological findings: non-neoplastic:
not specified

Effect levels

Dose descriptor:
NOAEL
Effect level:
14 700 ppm
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: body weight, histopathological findings

Target system / organ toxicity

Critical effects observed:
not specified

Any other information on results incl. tables

Mortality and body weight

 Dose  Males  Mean bw at week 7  Females  Mean bw at week 7    
 % Mortality  % of control  Mortality  % of control      
 1.47  0/5  94  0/5  95      
 2.15  0/5  73  0/5  76      
 3.15  0/5  60  0/5  68      
4.6  4/5  60  3/5  38      
 6.8  5/5  n/a  5/5  n/a      

Applicant's summary and conclusion

Conclusions:
In this dose range finding study the NOAEL.was at lowest dose level at 14700 ppm (corresponding to calculated 1935 mg/kg bw/day).
MTD calculated were 10000 ppm which was employed in a subsequent carcinogenicity study in rats.
Executive summary:

Groups of 5 male and 5 female rats were administered PBO at levels 14700, 21500, 31500, 46000, and 68000 ppm included in the diet. groups of five control animals of each sex were administered a basal diet only. Calculated daily dose levels were 1323, 1935, 2835, 4140, 6120 mg/kg bw/day.

The period of administration of the test chemical was 7 weeks, followed by 1 week of additional observation. Each animal was weighed twice per week At the end of the subchronic studies, all animals were killed by CO2- inhalation and necropsied. The lowest doses at which clinical and histopathologic findings were observed were 21,500 ppm in the male and female rats thus a NOAEL of 14700 ppm was identified. (1323 mg/kg bw/day).